N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide

C20H23N5O4 — CID 89036822

IUPACN'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide
SMILESCNCCNc1ccc(O)c2c1C(=O)c1c(O)ccc(NCC/N=C/N)c1C2=O
InChIInChI=1S/C20H23N5O4/c1-22-6-8-24-11-2-4-13(26)17-15(11)19(28)18-14(27)5-3-12(16(18)20(17)29)25-9-7-23-10-21/h2-5,10,22,24-27H,6-9H2,1H3,(H2,21,23)
InChIKeyRMUSVQQTMDEADA-UHFFFAOYSA-N
MW397.44 g/mol
LogP0.90
Rot. Bonds8

About N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide

N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide (PubChem CID 89036822) has the molecular formula C20H23N5O4 and a molecular weight of 397.44 g/mol. Its IUPAC name is N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide.

Molecular Properties

Compound NameN'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide
PubChem CID89036822
Molecular FormulaC20H23N5O4
Molecular Weight397.44 g/mol
Exact Mass397.18
IUPAC NameN'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide
SMILESCNCCNc1ccc(O)c2c1C(=O)c1c(O)ccc(NCC/N=C/N)c1C2=O
InChIInChI=1S/C20H23N5O4/c1-22-6-8-24-11-2-4-13(26)17-15(11)19(28)18-14(27)5-3-12(16(18)20(17)29)25-9-7-23-10-21/h2-5,10,22,24-27H,6-9H2,1H3,(H2,21,23)
InChIKeyRMUSVQQTMDEADA-UHFFFAOYSA-N
XLogP0.90
TPSA149.07 Ų
H-Bond Donors6
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500397.44
LogP ≤ 50.90
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'anthranil_one_A(38)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroquinone', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide?
The IUPAC name of N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide (CID 89036822) is N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide.
What is the SMILES notation for N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide?
The canonical SMILES for N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide is CNCCNc1ccc(O)c2c1C(=O)c1c(O)ccc(NCC/N=C/N)c1C2=O.
What is the InChIKey of N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide?
The InChIKey is RMUSVQQTMDEADA-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23N5O4/c1-22-6-8-24-11-2-4-13(26)17-15(11)19(28)18-14(27)5-3-12(16(18)20(17)29)25-9-7-23-10-21/h2-5,10,22,24-27H,6-9H2,1H3,(H2,21,23).
What are the key properties of N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide?
N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide has a molecular weight of 397.44 g/mol, XLogP of 0.90, 8 rotatable bonds, 6 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N'-[2-[[4,8-dihydroxy-5-[2-(methylamino)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl]methanimidamide is sourced from PubChem (CID 89036822), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).